Current Drug Metabolism aims to cover all the latest and outstanding developments in drug metabolism, pharmacokinetics, and drug disposition. The journal serves as an international forum for the publication of full-length/mini review, research articles and guest edited issues in drug metabolism. Current Drug Metabolism is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the most important developments. The journal covers the following general topic areas: pharmaceutics, pharmacokinetics, toxicology, and most importantly drug metabolism.

More specifically, in vitro and in vivo drug metabolism of phase I and phase II enzymes or metabolic pathways; drug-drug interactions and enzyme kinetics; pharmacokinetics, pharmacokinetic-pharmacodynamic modeling, and toxicokinetics; interspecies differences in metabolism or pharmacokinetics, species scaling and extrapolations; drug transporters; target organ toxicity and interindividual variability in drug exposure-response; extrahepatic metabolism; bioactivation, reactive metabolites, and developments for the identification of drug metabolites. Preclinical and clinical reviews describing the drug metabolism and pharmacokinetics of marketed drugs or drug classes.

《当代药物代谢》旨在涵盖药物代谢、药代动力学和药物处置方面的所有最新和杰出发展。该期刊是发表药物代谢领域全文/简短评论、研究文章和客座编辑问题的国际论坛。《当代药物代谢》是希望随时了解最重要发展的学术、临床、政府和制药科学家的必备期刊。该期刊涵盖以下一般主题领域：药剂学、药代动力学、毒理学，最重要的是药物代谢。

更具体地说，I 期和 II 期酶或代谢途径的体外和体内药物代谢；药物-药物相互作用和酶动力学；药代动力学、药代动力学-药效学建模和毒代动力学；代谢或药代动力学的物种间差异、物种缩放和推断；药物转运蛋白；靶器官毒性和药物暴露反应的个体间差异；肝外代谢；生物活化、反应性代谢物和药物代谢物的鉴定进展。描述上市药物或药物类别的药物代谢和药代动力学的临床前和临床评论。

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映医学-生化与分子生物学领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为2.1，平均审稿速度为 偏慢,4-8周 ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。